HU0600868D0 - 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation - Google Patents

5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation

Info

Publication number
HU0600868D0
HU0600868D0 HU0600868A HUP0600868A HU0600868D0 HU 0600868 D0 HU0600868 D0 HU 0600868D0 HU 0600868 A HU0600868 A HU 0600868A HU P0600868 A HUP0600868 A HU P0600868A HU 0600868 D0 HU0600868 D0 HU 0600868D0
Authority
HU
Hungary
Prior art keywords
polimorphs
benzisothiazol
indol
piperazinyl
dihydro
Prior art date
Application number
HU0600868A
Other languages
Hungarian (hu)
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU0600868A priority Critical patent/HUP0600868A3/en
Publication of HU0600868D0 publication Critical patent/HU0600868D0/en
Priority to EA200900725A priority patent/EA200900725A1/en
Priority to EP07848771A priority patent/EP2084156A1/en
Priority to PCT/HU2007/000112 priority patent/WO2008062244A1/en
Priority to US12/516,094 priority patent/US20100081668A1/en
Publication of HUP0600868A2 publication Critical patent/HUP0600868A2/en
Publication of HUP0600868A3 publication Critical patent/HUP0600868A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0600868A 2006-11-24 2006-11-24 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation HUP0600868A3 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HU0600868A HUP0600868A3 (en) 2006-11-24 2006-11-24 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation
EA200900725A EA200900725A1 (en) 2006-11-24 2007-11-23 POLYMORPHES OF HYDROBROMIDE 5- {2- [4- (1,2-BENZOISOTHIAZOL-3-IL) -1-PIPERAZINYL] ETHYL} -6-HLOR-1,3-DIGYDRO-2N-INDOL-2-IT AND THEIR METHOD OF OBTAINING
EP07848771A EP2084156A1 (en) 2006-11-24 2007-11-23 Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
PCT/HU2007/000112 WO2008062244A1 (en) 2006-11-24 2007-11-23 Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
US12/516,094 US20100081668A1 (en) 2006-11-24 2007-11-23 Polymorphs of 5--6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0600868A HUP0600868A3 (en) 2006-11-24 2006-11-24 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation

Publications (3)

Publication Number Publication Date
HU0600868D0 true HU0600868D0 (en) 2007-01-29
HUP0600868A2 HUP0600868A2 (en) 2008-09-29
HUP0600868A3 HUP0600868A3 (en) 2009-03-30

Family

ID=89987153

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0600868A HUP0600868A3 (en) 2006-11-24 2006-11-24 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation

Country Status (5)

Country Link
US (1) US20100081668A1 (en)
EP (1) EP2084156A1 (en)
EA (1) EA200900725A1 (en)
HU (1) HUP0600868A3 (en)
WO (1) WO2008062244A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091156A1 (en) * 2007-12-17 2009-09-03 Astrazeneca Ab SALTS OF (3 - {[[3- (6-AMINO-2-BUTOXY-8-OXO-7,8-DIHIDRO-9H-PURIN-9-IL) PROPYL] (3-MORFOLIN-4-ILPROPIL) AMINO] METHYL} PHENYL) METHYL ACETATE
EP2739446A4 (en) 2011-08-03 2015-09-16 Diverse Barrel Solutions Pty Ltd System and method for the reconditioning of barrels including a robotic arm with a removable laser module

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (en) * 1987-03-02 1994-02-23 Pfizer PIPERAZINIL HETERO-CYCLIC COMPOUNDS AND PROCEDURE FOR THE PREPARATION
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5338846A (en) * 1992-08-26 1994-08-16 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Pharmaceutical compositions containing piperazinyl-heterocyclic compounds for treating psychiatric disorders
JP2007514001A (en) * 2003-12-18 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド Ziprasidone base polymorphic form B2
ES2250001B1 (en) * 2004-09-29 2007-06-01 Medichem, S.A. PROCESS FOR THE PURIFICATION OF ZIPRASIDONA.

Also Published As

Publication number Publication date
WO2008062244A8 (en) 2009-06-11
WO2008062244A1 (en) 2008-05-29
EP2084156A1 (en) 2009-08-05
EA200900725A1 (en) 2009-10-30
HUP0600868A2 (en) 2008-09-29
US20100081668A1 (en) 2010-04-01
HUP0600868A3 (en) 2009-03-30

Similar Documents

Publication Publication Date Title
HK1203959A1 (en) Method for the preparation of 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl)-4-fluoro-benzyl -2h-phthalazin-1-one 1-()-4-[5-[(34--4--1-) -2-
IL196876A0 (en) 2-(heterocyclylbenzyl)pyridazinone derivatives
IL236883A0 (en) Intermediate compounds for the preparation of (s)-n-((s)-1-cyclohexyl-2-{(s)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide
IL184427A0 (en) Thiazole-4-carboxamide derivatives as mglur5 antagonists
EP2244576A4 (en) 3,5-substituted-1,3-oxazolidin-2-one derivatives
IL193530A0 (en) Benzothiazol derivatives as beta2 adrenoreceptor agonists
EP2079504B8 (en) Integrated humidifier chamber & lid
IL195511A0 (en) 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]
EP1932347A4 (en) Localized media content management
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
IL199014A0 (en) 4-hydroxy-2-oxo-2,3-dihydro-1,3-
IL185242A0 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
IL185327A0 (en) PYRAZINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
HK1140106A1 (en) Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof -2-
SI2176229T1 (en) Novel crystalline form of 3-(difluormethyl)-1-methyl-n -(3',4',5'-trifluorš1,1'-biphenylć-2-yl)-1h-pyrazol-4-carboxamide
GB0820250D0 (en) Mutant HSV, materials and methods for generation of mutant HSV
GB0718999D0 (en) Merocyanine derivatives
HUP0600868A3 (en) 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation
HUP0600347A3 (en) Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon) and the intermediate
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
AU2008306604A8 (en) Process for the preparation of zolmitriptan, salts and solvates thereof
EP2231558A4 (en) 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
IL182058A0 (en) Process for preparing ziprasidone
HU0600834D0 (en) Process for the preparation of 2-[2-(1-piperazinyl)-ethoxy]
IL183612A0 (en) Process for prepaing ziprasidone mesylate

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished